Company Directory > MedTech > CREWT Medical Systems, Inc.
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of CREWT Medical Systems, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
CREWT Medical Systems is a Japanese medical device company founded in 2013 as a spin-off from a major optical device manufacturer and affiliated with the University of Tokyo. The company specializes in the development of human-centric optometry instruments, most notably the world's first head-mounted perimeter, 'imo', which is designed to improve the quality of vision (QOV) and streamline glaucoma diagnosis. The company leverages cutting-edge lens design techniques and software engineering to create portable, efficient diagnostic tools that do not require darkrooms. Their product portfolio includes the 'IMOvifa' smart perimeter and 'imo-Plus CS' for contrast sensitivity testing, both of which are designed to reduce patient burden and improve clinical workflow efficiency.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:
Industry:Medical Devices
Sub-Industry:Ophthalmology / Optometry Instruments
SIZE & FINANCIALS
Employees:1-50
Founded:2013
Ownership:private
Status:operating
FUNDING
Total Raised:$9.21M
Investors:Fuyo General Lease Co., Ltd.
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A
Modalities:Diagnostic Medical Devices
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:University of Tokyo (Joint development), Kinki University (Joint development), Fuyo General Lease Co., Ltd. (Capital and Business Alliance)
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Tetsuya Eguchi - CEO
LINKS
Website:crewt.co.jp
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with CREWT Medical Systems, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.